Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

MonoGen closes US$12.4 million financing

Reading Time 1 minute read Subscribe

GMP Securities

On May 15, 2007, medical diagnostics company MonoGen, Inc. announced that it had closed a short form prospectus equity offering for aggregate proceeds of US$12.4 million, including proceeds received upon the exercise of the underwriters' over-allotment option. The syndicate of underwriters for this financing was led by GMP Securities L.P., and included Canaccord Capital Corporation and Paradigm Capital Inc. The underwriters were advised by Rubin Rapuch, Georges Dubé and Jeffrey Klam of Fasken Martineau.


    Receive email updates from our team